BRPI0920240A2 - formulação de adjuvante de combinação - Google Patents

formulação de adjuvante de combinação

Info

Publication number: BRPI0920240A2
Authority: BR; Brazil
Prior art keywords: adjuvant formulation; combination adjuvant; combination; formulation; adjuvant
Prior art date: 2008-10-16

Application number

BRPI0920240A

Other languages

English (en)

Inventor

Andrew Potter

George Mutwiri

Jason Kindrachuck

Jennifer Kovacs-Nolan

Lorne Babiuk

Melissa Elliott

Mi-Na Kweon

Robert Hancock

Scott Halperin

Song Lee

Sylvia Van Drunen Littel-Van Den Hurk

Volker Gerdts

Original Assignee

Univ Dalhousie

Internat Vaccine Inst

Univ British Columbia

Univ Saskatchewan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-16

Filing date

2009-10-15

Publication date

2016-08-02

2009-10-15 Application filed by Univ Dalhousie, Internat Vaccine Inst, Univ British Columbia, Univ Saskatchewan filed Critical Univ Dalhousie

2016-08-02 Publication of BRPI0920240A2 publication Critical patent/BRPI0920240A2/pt

2021-01-19 Publication of BRPI0920240B1 publication Critical patent/BRPI0920240B1/pt

2021-05-25 Publication of BRPI0920240B8 publication Critical patent/BRPI0920240B8/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0920240A 2008-10-16 2009-10-15 composição adjuvante BRPI0920240B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US19622608P	2008-10-16	2008-10-16
US61/196.226		2008-10-16
PCT/CA2009/001463 WO2010043039A1 (en)	2008-10-16	2009-10-15	Combination adjuvant formulation

Publications (3)

Publication Number	Publication Date
BRPI0920240A2 true BRPI0920240A2 (pt)	2016-08-02
BRPI0920240B1 BRPI0920240B1 (pt)	2021-01-19
BRPI0920240B8 BRPI0920240B8 (pt)	2021-05-25

Family

ID=42106164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0920240A BRPI0920240B8 (pt)	2008-10-16	2009-10-15	composição adjuvante

Country Status (9)

Country	Link
US (2)	US9061001B2 (pt)
EP (1)	EP2344522B1 (pt)
AU (1)	AU2009304552B2 (pt)
BR (1)	BRPI0920240B8 (pt)
CA (1)	CA2737352C (pt)
DK (1)	DK2344522T3 (pt)
HU (1)	HUE028497T2 (pt)
NZ (2)	NZ601345A (pt)
WO (1)	WO2010043039A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2009304552B2 (en) *	2008-10-16	2015-02-19	Dalhousie University	Combination adjuvant formulation
US8999349B2 (en) *	2010-07-27	2015-04-07	The Regents Of The University Of California	HMGB1-derived peptides enhance immune response to antigens
WO2013034982A2 (en) *	2011-09-09	2013-03-14	The University Of British Columbia	Immunomodulatory peptides for treatment of progressive neurodegenerative diseases
US10722569B2 (en)	2012-07-05	2020-07-28	Children's Medical Center Corporation	Bacterial biofilm matrix as a platform for protein delivery
EP3024936B1 (en)	2013-07-25	2019-09-04	Exicure, Inc.	Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
TR201908550T4 (tr)	2014-06-04	2019-07-22	Exicure Inc	Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi.
US11213593B2 (en)	2014-11-21	2022-01-04	Northwestern University	Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
CN107206030B (zh)	2014-12-08	2020-11-17	Gi生物群系公司	包含生酸拟杆菌作为有效成分的用于预防或治疗代谢性疾病的药学组合物
WO2017011919A1 (en) *	2015-07-22	2017-01-26	University Of Saskatchewan	Mycoplasma vaccines and uses thereof
WO2017087844A1 (en)	2015-11-18	2017-05-26	University Of Maryland, College Park	Polyphosphazenes, methods of making, and uses thereof
TW201731525A (zh) *	2015-11-25	2017-09-16	薩斯喀徹溫大學	治療、預防及診斷豬流行性下痢病毒感染之方法
US10624947B2 (en)	2016-03-29	2020-04-21	Indiana University Research And Technology Corporation	Bactericidal peptides and uses thereof
WO2017172929A1 (en) *	2016-03-29	2017-10-05	Indiana University Research And Technology Corporation	Bactericidal peptides and uses thereof
US10858483B2 (en)	2016-07-06	2020-12-08	University Of Maryland, College Park	Polyphosphazene polyelectrolytes and uses thereof
WO2018039629A2 (en)	2016-08-25	2018-03-01	Northwestern University	Micellar spherical nucleic acids from thermoresponsive, traceless templates
US11793858B2 (en)	2018-04-13	2023-10-24	Indiana University Research And Technology Corporation	Bactericidal peptides and uses thereof
KR102725189B1 (ko) *	2018-11-01	2024-10-31	에스케이바이오사이언스(주)	재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
CA3131800A1 (en) *	2019-02-28	2020-09-03	University Of Saskatchewan	Lawsonia intracellularis compositions and methods of using the same
BR112022021258A2 (pt)	2020-04-20	2023-01-17	Univ Saskatchewan	Composições e métodos para prevenir, controlar e diagnosticar infecções micobacterianas
WO2023288263A1 (en)	2021-07-16	2023-01-19	The Board Of Trustees Of The University Of Illinois	Universal vaccine for influenza virus based on tetrameric m2 protein incorporated into nanodiscs

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5985354A (en)	1995-06-07	1999-11-16	Brown University Research Foundation	Preparation of multiwall polymeric microcapsules from hydrophilic polymers
US5053451A (en)	1990-01-19	1991-10-01	The Pennsylvania Research Corporation	Ionically cross-linkable polyphosphazene: poly(bis(carboxylatophenoxy) phosphazene) and its hydrogels and membranes
US5149543A (en)	1990-10-05	1992-09-22	Massachusetts Institute Of Technology	Ionically cross-linked polymeric microcapsules
US5562909A (en)	1993-07-12	1996-10-08	Massachusetts Institute Of Technology	Phosphazene polyelectrolytes as immunoadjuvants
US5500161A (en)	1993-09-21	1996-03-19	Massachusetts Institute Of Technology And Virus Research Institute	Method for making hydrophobic polymeric microparticles
US5855895A (en)	1995-06-07	1999-01-05	Virus Research Institute	Polyphosphazene polyelectrolyte immunoadjuvants
EP1167379A3 (en)	1994-07-15	2004-09-08	University Of Iowa Research Foundation	Immunomodulatory oligonucleotides
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US6239116B1 (en)	1994-07-15	2001-05-29	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US5891444A (en)	1995-06-07	1999-04-06	Virus Research Institute, Inc.	HIV-1 prophylactic composition and method
US5807757A (en)	1996-07-02	1998-09-15	Virus Research Institute, Inc.	Preparation of ionically cross-linked polyphosphazene microspheresy by coacervation
WO1998037919A1 (en)	1997-02-28	1998-09-03	University Of Iowa Research Foundation	USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
EP1003531B1 (en)	1997-05-20	2007-08-22	Ottawa Health Research Institute	Processes for preparing nucleic acid constructs
US5760271A (en)	1997-08-18	1998-06-02	Virus Research Institute, Inc.	Production of polyorganophosphazenes
US6207171B1 (en)	1998-03-27	2001-03-27	Avant Immunotherapeutics, Inc.	Polyphosphazene microspheres
AU760549B2 (en)	1998-04-03	2003-05-15	University Of Iowa Research Foundation, The	Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
US6261573B1 (en)	1998-10-30	2001-07-17	Avant Immunotherapeutics, Inc.	Immunoadjuvants
NZ512980A (en)	1998-12-17	2003-07-25	Aventis Pasteur	Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation
AU7085400A (en)	1999-09-02	2001-03-26	Antigenics, Inc.	Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof
AU783118B2 (en)	1999-09-27	2005-09-29	Coley Pharmaceutical Gmbh	Methods related to immunostimulatory nucleic acid-induced interferon
US6921535B2 (en) *	2000-06-23	2005-07-26	Akzo Nobel N.V.	Attenuated Bovine Respiratory Syncytial virus
ATE411054T1 (de)	2001-08-17	2008-10-15	Coley Pharm Gmbh	Kombinations-motif-immunstimulierende oligonukleotide mit verbesserter wirkung
US20050238660A1 (en) *	2001-10-06	2005-10-27	Babiuk Lorne A	Cpg formulations and related methods
US20030139364A1 (en)	2001-10-12	2003-07-24	University Of Iowa Research Foundation	Methods and products for enhancing immune responses using imidazoquinoline compounds
US20040161470A1 (en)	2002-11-22	2004-08-19	Alexander Andrianov	Preparation of polyphosphazene microspheres
CA2548992A1 (en) *	2003-12-11	2005-08-11	Vaxdesign Corporation	Immunotherapy compositions, method of making and method of use thereof
US20060008466A1 (en) *	2004-07-07	2006-01-12	University Of Saskatchewan	Methods for treating and preventing microbial infections
CA2629751A1 (en)	2004-11-12	2006-05-18	The University Of British Columbia	Antimicrobial peptides
CA2660668C (en)	2006-08-21	2016-06-28	The University Of British Columbia	Small cationic antimicrobial peptides
US9102754B2 (en) *	2007-06-28	2015-08-11	University Of Saskatchewan	Immunomodulatory compositions and methods for treating disease with modified host defense peptides
US20090186050A1 (en) *	2007-11-16	2009-07-23	Fouchier Ron A M	Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
AU2009304552B2 (en) *	2008-10-16	2015-02-19	Dalhousie University	Combination adjuvant formulation

2009
- 2009-10-15 AU AU2009304552A patent/AU2009304552B2/en not_active Ceased
- 2009-10-15 NZ NZ601345A patent/NZ601345A/en not_active IP Right Cessation
- 2009-10-15 EP EP09820153.6A patent/EP2344522B1/en active Active
- 2009-10-15 HU HUE09820153A patent/HUE028497T2/en unknown
- 2009-10-15 BR BRPI0920240A patent/BRPI0920240B8/pt not_active IP Right Cessation
- 2009-10-15 WO PCT/CA2009/001463 patent/WO2010043039A1/en not_active Ceased
- 2009-10-15 DK DK09820153.6T patent/DK2344522T3/en active
- 2009-10-15 CA CA2737352A patent/CA2737352C/en active Active
- 2009-10-15 NZ NZ591925A patent/NZ591925A/xx not_active IP Right Cessation
- 2009-10-15 US US12/587,955 patent/US9061001B2/en active Active
2013
- 2013-02-15 US US13/768,694 patent/US9408908B2/en active Active

Also Published As

Publication number	Publication date
EP2344522A4 (en)	2013-09-04
BRPI0920240B8 (pt)	2021-05-25
CA2737352C (en)	2017-06-27
US20100239611A1 (en)	2010-09-23
EP2344522A1 (en)	2011-07-20
AU2009304552B2 (en)	2015-02-19
US20140248313A1 (en)	2014-09-04
HUE028497T2 (en)	2016-12-28
EP2344522B1 (en)	2016-01-27
NZ591925A (en)	2012-09-28
AU2009304552A2 (en)	2011-07-07
WO2010043039A1 (en)	2010-04-22
AU2009304552A1 (en)	2010-04-22
US9061001B2 (en)	2015-06-23
CA2737352A1 (en)	2010-04-22
BRPI0920240B1 (pt)	2021-01-19
DK2344522T3 (en)	2016-04-18
NZ601345A (en)	2014-05-30
US9408908B2 (en)	2016-08-09

Legal Events

Date	Code	Title	Description
2016-08-09	B15I	Others concerning applications: loss of priority	Free format text: PERDA DA PRIORIDADE US 61/196.226 DE 16/10/2008, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O E NO ART. 28 DO ATO NORMATIVO 128/1997, POR NAO ATENDER AO DISPOSTO NO ART. 27 DO ATO NORMATIVO 128/1997, POIS NAO FOI APRESENTADA CESSAO DA REFERIDA PRIORIDADE, QUE POSSUI DEPOSITANTE DIFERENTE DO DEPOSITANTE DA FASE NACIONAL.
2016-11-29	B12F	Other appeals [chapter 12.6 patent gazette]
2018-01-16	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-07-02	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-09-03	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-12-08	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-01-19	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2025-09-16	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 16A ANUIDADE.
2026-01-06	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2854 DE 16-09-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0920240A2 (pt)	2016-08-02	formulação de adjuvante de combinação
BRPI0921327A2 (pt)	2015-08-25	Combinação de herbicida-protetor
FIC20240018I1 (fi)	2024-06-04	Vamoroloni
DK2634232T3 (da)	2022-06-07	Sammensætninger
PT3072906T (pt)	2021-12-14	Formulação de anticorpos
PT2813570T (pt)	2018-02-12	Resumo
BRPI0909644A2 (pt)	2015-09-22	dispositivo de foto-epilação
EP2381760A4 (en)	2013-01-16	CORN PROTEIN COMPOSITION
BRPI0907376A2 (pt)	2015-07-14	Fotobiorretador
PT3045471T (pt)	2017-06-14	Resumo
UA18712S (uk)	2009-04-10	Шоколад
BRPI0914649A2 (pt)	2015-07-07	Piprazolo-quinazolinas
BRPI1009465A2 (pt)	2015-08-18	Formulação
BRPI0814188A2 (pt)	2014-10-14	Formulações
BRPI0907522A2 (pt)	2019-09-24	biarlamidas
EP2296713A4 (en)	2013-01-09	DISINFECTANT FORMULATION
EP2280264A4 (en)	2016-04-20	STANDARD AGENTS
DE112009000183A5 (de)	2011-02-03	Sicherheitsvorreiber
BRPI0917673A2 (pt)	2015-08-18	Combinação de herbicida-protetor compreendendo difluorometanossulfonilanilidas substituidas por dimetoxitriazinila
BRPI0909634A2 (pt)	2015-09-22	2-aminoquinolinas
BRPI0922728A2 (pt)	2019-09-24	combinação de herbicida-antídoto
EP2207567A4 (en)	2013-05-01	IMMUNOGENIC FORMULATIONS
DE112009001946A5 (de)	2011-07-14	Mobelauszugsführung
BRPI0909637A2 (pt)	2015-09-22	2-aminoquinolinas
BRPI0907863A2 (pt)	2019-09-24	pirrolopirimidinacarboxamidas